Sequoia China-backed health tech unicorn Medlinker has set up a 500-million-yuan ($75.9 million) industry investment fund, while Gene+ Technology has closed over 250 million yuan ($38 million) in a Series B+ round of financing led by Huagai Capital.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in